Fluorinated Microparticles for Cell Aggregate Oxygenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for drug screening and tissue engineering face challenges in providing sufficient oxygenation to cell aggregates, such as organoids and spheroids, leading to hypoxic environments and limited tissue size, which restricts their application and suitability for drug screening and tissue development.
Innovation Solution
The use of fluorinated polymeric microparticles, specifically chitosan microparticles with immobilized perfluorocarbons, is introduced to enhance oxygen transport within cell aggregates, prepared using methods like mini-emulsion, electro-spraying, or microfluidics, to maintain high local oxygen concentrations and reduce hypoxia.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If cell aggregates are grown to larger sizes for improved drug screening relevance, then the model becomes more representative of human organs, but oxygen supply becomes insufficient leading to hypoxic and necrotic cores
Solution Approach 1:
The patent introduces oxygen-carrying microparticles as intermediary carriers that transport oxygen from the outer regions to the inner core of cell aggregates. These microparticles act as mobile oxygen reservoirs, bridging the oxygen supply gap in large tissue models without requiring vascularization or external perfusion systems.
Solution Approach 2:
The patent modifies the physical and chemical parameters of the tissue microenvironment by incorporating microparticles with high oxygen-carrying capacity. This changes the oxygen diffusion parameters and consumption rates, allowing large cell aggregates to maintain adequate oxygen levels throughout their volume without forming hypoxic cores.
2Object-affected harmful factors
If conventional oxygen transport methods (artificial microvessels, fluid perfusion) are used to improve oxygenation, then oxygen supply increases, but the system complexity and manufacturing difficulty increase
Solution Approach 1:
The oxygen-carrying microparticles are designed to be self-contained units that autonomously transport and release oxygen within the cell aggregate without requiring external power sources, control systems, or complex vascular networks. The particles self-regulate oxygen release based on local concentration gradients, eliminating the need for active pumping or external perfusion systems.
Solution Approach 2:
The microparticles utilize porous or permeable material structures that allow passive oxygen diffusion and exchange with the surrounding cellular environment. This enables continuous oxygen supply through simple diffusion gradients without requiring active transport mechanisms or complex engineered vasculature.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively increases oxygenation within cell aggregates, reducing hypoxic and necrotic regions, allowing for the growth of larger and more complex tissues by improving localized oxygen transport, thereby enhancing cell proliferation and viability.
Implementation Method 1
fluorinated polymeric microparticles, specifically chitosan microparticles with immobilized perfluorocarbons, is introduced to enhance oxygen transport within cell aggregates
Data Source
AI summary
A method of preparing and obtaining cell aggregates having increased oxygenation abilities. The method includes the preparation of fluorinated polymeric microparticles. Once the fluorinated polymeric microparticles are prepared, they are combined with mammalian cells to create the cell aggregates having increased oxygenation.